In support to these findings, hepatocyte-specific deletion of Sirt1 resulted in hepatic steatosis and inflammation [111], whereas both transgenic SIRT1 mice and overexpression of SIRT1 specifically in the liver showed lower hepatic steatosis along with better glucose tolerance [112]. Here, SIRT1 is linked to fatty liver disease.